Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) Groups

This study has been terminated.
(Terminated to financial cut)
Sponsor:
Collaborator:
Levanger Hospital
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184405
First received: September 15, 2005
Last updated: January 5, 2009
Last verified: January 2009
  Purpose

This is a study evaluating changes in quality of life and global functioning across and after a manualized peer-group preventive intervention for children of parents with psychiatric or addictive problems.


Condition Phase
Psychiatric Disorder NOS
Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Preventive Peer Groups for Children of Parents With Psychiatric and Addictive Problems (COPP). Child Experiences and Observed Child Changes Following the Intervention

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Enrollment: 6
Study Start Date: March 2005
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Self-reported quality of life and based on the group-interviews "ILK" and "Kindl" and general adaptive functioning (CGAS) as reported by teachers and parents will be measured before, after and at follow-up relative to the manualized peer-group preventive intervention. Parents will also complete self-reports on anxiety and depressive symptoms, personality, bonding and attribution before the intervention.

  Eligibility

Ages Eligible for Study:   8 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Families with at least one parent with psychiatric or addictive problem

Criteria

Inclusion Criteria:

  • Family including Parent with psychiatric or addictive problems

Exclusion Criteria:

  • acute severe disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184405

Locations
Norway
Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health
Trondheim, Norway, N-7089
Sponsors and Collaborators
Norwegian University of Science and Technology
Levanger Hospital
Investigators
Principal Investigator: Tormod Rimehaug, Asst. Prof. Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health
  More Information

No publications provided

Responsible Party: ass professor Tormod Rimehaug, Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184405     History of Changes
Other Study ID Numbers: 4.2005.393
Study First Received: September 15, 2005
Last Updated: January 5, 2009
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Parents with psychiatric or addictive problems

Additional relevant MeSH terms:
Mental Disorders

ClinicalTrials.gov processed this record on September 16, 2014